Reduced binding of TFIID to transcriptionally compromised mutants of VP16.

Crystal structure of TFIID TATA-box binding protein.

Fitness of Escherichia coli mutants with reduced susceptibility to tigecycline.

Functional binding of the "TATA" box binding component of transcription factor TFIID to the -30 region of TATA-less promoters.

Direct and selective binding of an acidic transcriptional activation domain to the TATA-box factor TFIID.

A bipartite DNA binding domain composed of direct repeats in the TATA box binding factor TFIID.

Cloning of a transcriptionally active human TATA binding factor.

Transcription factor TFIID induces DNA bending upon binding to the TATA element.

Suppression of conformation-compromised mutants of Salmonella enterica serovar Typhimurium MelB.

A comparison of the DNA bending activities of the DNA binding proteins CRP and TFIID.

Analysis of structure-function relationships of yeast TATA box binding factor TFIID.

Antigen-binding mutants of mouse myeloma cells.

Compromised structure and function of HDAC8 mutants identified in Cornelia de Lange Syndrome spectrum disorders.

Isolation and characterization of the Drosophila gene encoding the TATA box binding protein, TFIID.

DNA-binding and transcriptional properties of human transcription factor TFIID after mild proteolysis.

Characterization of Caenorhabditis elegans lectin-binding mutants.

Histidine mutants requiring adenine: selection of mutants with reduced hisG expression in Salmonella typhimurium.

Transcriptionally active non-ligand binding oestrogen receptors in breast cancer.

Mechanism of transcriptional antirepression by GAL4-VP16.

Identification of human TFIID components and direct interaction between a 250-kDa polypeptide and the TATA box-binding protein (TFIID tau).

Similarity between the DNA-binding domains of IHF protein and TFIID protein.

A downstream initiation element required for efficient TATA box binding and in vitro function of TFIID.

Selection and characterisation of Staphylococcus aureus mutants with reduced susceptibility to the investigational oxazolidinone MRX-I.

Reduced phototropism in pks mutants may be due to altered auxin-regulated gene expression or reduced lateral auxin transport.

Differential binding of prohibitin-2 to estrogen receptor α and to drug-resistant ERα mutants.

Suggest Documents

Crystal structure of TFIID TATA-box binding protein.

Fitness of Escherichia coli mutants with reduced susceptibility to tigecycline.

Functional binding of the "TATA" box binding component of transcription factor TFIID to the -30 region of TATA-less promoters.

Direct and selective binding of an acidic transcriptional activation domain to the TATA-box factor TFIID.

A bipartite DNA binding domain composed of direct repeats in the TATA box binding factor TFIID.

Cloning of a transcriptionally active human TATA binding factor.

Transcription factor TFIID induces DNA bending upon binding to the TATA element.

Suppression of conformation-compromised mutants of Salmonella enterica serovar Typhimurium MelB.

A comparison of the DNA bending activities of the DNA binding proteins CRP and TFIID.

Analysis of structure-function relationships of yeast TATA box binding factor TFIID.

Antigen-binding mutants of mouse myeloma cells.

Compromised structure and function of HDAC8 mutants identified in Cornelia de Lange Syndrome spectrum disorders.

Isolation and characterization of the Drosophila gene encoding the TATA box binding protein, TFIID.

DNA-binding and transcriptional properties of human transcription factor TFIID after mild proteolysis.

Characterization of Caenorhabditis elegans lectin-binding mutants.

Histidine mutants requiring adenine: selection of mutants with reduced hisG expression in Salmonella typhimurium.

Transcriptionally active non-ligand binding oestrogen receptors in breast cancer.

Mechanism of transcriptional antirepression by GAL4-VP16.

Identification of human TFIID components and direct interaction between a 250-kDa polypeptide and the TATA box-binding protein (TFIID tau).

Similarity between the DNA-binding domains of IHF protein and TFIID protein.

A downstream initiation element required for efficient TATA box binding and in vitro function of TFIID.

Selection and characterisation of Staphylococcus aureus mutants with reduced susceptibility to the investigational oxazolidinone MRX-I.

Reduced phototropism in pks mutants may be due to altered auxin-regulated gene expression or reduced lateral auxin transport.

Differential binding of prohibitin-2 to estrogen receptor α and to drug-resistant ERα mutants.

Reduced binding of TFIID to transcriptionally compromised mutants of VP16.

Recommend Documents

Follow Us